Dosimetry of CT-guided volumetric IR-192 brain implant.

[1]  U. Rosenow,et al.  125I interstitial brachytherapy for primary malignant brain tumors: technical aspects of treatment planning and implantation methods. , 1984, International journal of radiation oncology, biology, physics.

[2]  J. A. Marchosky,et al.  Dosimetry considerations of CT-guided volumetric interstitial brachytherapy of malignant brain tumors , 1984 .

[3]  R. Drzymala,et al.  Interstitial brain irradiation by removable high-intensity iridium-192: Pre-clinical evaluation, dosimetric planning and bedside shielding , 1984 .

[4]  T. Naidich,et al.  CT-guided needle placement in the central nervous system: results in 146 consecutive patients. , 1984, AJR. American journal of roentgenology.

[5]  B A Kall,et al.  Transposition of volumetric information derived from computed tomography scanning into stereotactic space. , 1984, Surgical neurology.

[6]  Stephan J. Goerss,et al.  Computer Simulation for the Stereotactic Placement of Interstitial Radionuclide Sources into Computed Tomography-defined Tumor Volumes , 1984 .

[7]  P. Gutin,et al.  Brachytherapy of recurrent malignant brain tumors with removable high-activity iodine-125 sources. , 1984, Journal of neurosurgery.

[8]  K. Kovacs,et al.  Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors. , 1984, Journal of neurosurgery.

[9]  J. A. Marchosky,et al.  A simple stabilization device for intracranial aspiration procedures guided by computed tomography. , 1982, Radiology.

[10]  P. Gutin,et al.  Permanent and removable implants for the brachytherapy of brain tumors. , 1981, International journal of radiation oncology, biology, physics.